ADVM vs DNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

ADVM

52.6
AI Score
VS
DNA Wins

DNA

56.3
AI Score

Investment Advisor Scores

ADVM

53score
Recommendation
HOLD

DNA

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ADVM DNA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -70.0% -48.5% DNA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 52.6/100 56.3/100 DNA
Profit Margin 0.0% -219.6% ADVM
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ADVM 1M: +0.7% · 3M: +22.0% DNA 1M: -4.1% · 3M: +31.9%

Current Technical Phase

ADVM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.0 · Price: $4.32

DNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.3 · Price: $9.83

Fundamentals Snapshot

Metric ADVM DNA
Market Cap — —
Forward P/E -1.2 -3.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.7% -0.5%
Gross Margin — 0.7%
Operating Margin 0.0% -2.8%
EPS -8.56 -5.06
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DNA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.